tory capacity, a reduction in lung volumes, and evidence of 'alveolar-capillary block' was recorded by Baldwin, Cournand, and Richards (1949) and by Spain and Thomas (1950) , while Miller et al. (1959a) reported abnormalities of lung function in the absence of radiological changes. This paper reports more extensive studies of pulmonary function in 22 patients with scleroderma and correlates these findings with the clinical, radiological, electrocardiographic, and pathological findings. Particular attention is paid to the relation of the pulmonary findings to the extent of the skin changes. Evidence is presented to support the view that scleroderma is essentially a generalized disease, the extent of the visceral involvement being unrelated to the extent of the cutaneous manifestations.
MATERIAL AND METHODS
Twenty-two patients with seleroderma were studied, 17 females (aged 25 to 75, mean 51-2 years) and five males (aged 38 to 61, mean 46-4 years). Eighteen patients had been investigated previously as part of a larger study of the extra-pulmonary manifestations I Present address: King's College Hospital, London, S.E.5. of scleroderma (Lumb, F., to be published); the four others were referred from out-patient clinics for lung function tests. Raynaud's phenomenon, stiffness of the fingers, or joint pains had been present for two to 36 years (mean 10-2 years). Symptoms had been present for over 10 years in six patients. All patients had characteristic skin changes, which were localized to the fingers in eight but were more extensive in the remainder; 15 patients had radiological or biochemical evidence of gastro-intestinal involvement.
CLINICAL ASSESSMENT In the assessment of the symptoms and signs of cardiac and pulmonary disease, special attention was paid to the definition of exertional dyspnoea, changes in the skin of the thorax, thoracic mobility, and adventitious sounds. Respiratory symptoms were assessed by the use of a questionnaire (Fletcher and Tinker, 1961) . Chronic bronchitis is defined as the presence of cough or sputum for more than three months of the year.
Exercise tolerance was classified as follows: Grade Needham, Rogan, and McDonald (1954) . Total lung capacity (T.L.C.) was predicted from the simple regression based on height; 6% was added to predicted values to convert from ambient to body temperature (atmospheric pressure, water vapour saturation). Ventilatory response to exercise at a predetermined work level was measured in 19 patients during a five-minute stepping test previously described with normal standards (29±5 1./min.) from this laboratory (Gandevia, 1962 (95) 30 (35) 4-09 (99) 43 (47) 5 64 (83) 21 (34) 3 79 (76) 40 (40) 5 26 (105) 28 (40) 3-66 (90) 44 (50) 4-54 (87) 62 (43) 3-42 (71) 45 (41) 5-15 (115) 54 (43) 4-84 (108) 35 (36) 3-61 (80) 28 (31) 3-47 (74) 47 (43) 4-38 (88) 48 (49) 4 80 (70) 47 (35) 2 82 (63) 39 (36) 3 04(66) 31 ( CGreater than 10 increase in F.E.V.I., after bronchodilator aerosol.
an increased ventilatory response to exercise, two a reduced DLc,3 and one a lowered compliance.
In 12 patients the V.C. was reduced below 80% of the predicted values. The F.E.V.1 n was reduced below 70% of the V.C. in two patients (Nos. 7 and 15), and in three (Nos. 7, 17, and 20) a 10% increase in F.E.V.1.0 was found after bronchodilator aerosol. The total lung capacity was below 80% of the predicted value in seven subjects, all of whom had a reduced V.C., residual volume (R.V.), and functional residual capacity (F.R.C.). Three others (Nos. 2, 13, and 15) had a significant increase (above 120% predicted) in F.R.C. and R.V.; in one (No. 15) with scleroderma and 20 control subjects paired for age and sex. The range of results in the patients with scleroderma was from 2-3 to 28-7 ml./min./mm. Hg (mean 16 0+666) and in the control group from 14-0 to 27-8 ml./min./mm. Hg (mean 21-2+4-5). The range of the ratio of DLcJ/ body surface area for the control group was 8 8 to 17 8 and for the scleroderma patients from 16 to 15 9. Seven of the patients with scleroderma showed DLc, values below the lowest of the control group; five of these had a reduced V.C. and lung volumes.
Lung compliance was measured in 18 patients. The results ranged from 0065 to 0300 litre/cm. water (mean 0137 + 0-067) and from 0-107 to 0 360 litre/cm. water (mean 0 203 + 0 072) in the control group. Eight patients with scleroderma had compliance levels below those of the controls and below the lower limit of normal (0 100 litre/cm. water) accepted by this laboratory. Figure 4 shows a plot of the ratio of compliance to F.R.C. Five patients had values below those of the control group and below the normal range for this ratio of 0-038 given by Marshall (1957) . Three of the five also had a reduced V.C., but only one showed a defect in DLCO.
RELATION BETWEEN CLINICAL AND FUNCTIONAL
ABNORMALITIES There was no direct relation between the duration of symptoms attributable to scleroderma and the degree of pulmonary involvement. Three of the seven patients with multiple abnormalities in pulmonary function (Nos. 5, 13, 14, 18, 20, 21, and 22) (Nos. 20, 21, and 22) were severely affected. By contrast, the presence of abnormalities in the chest radiograph could be related to severe impairment of pulmonary function (Nos. 13, 18, 20, 21, and 22) . Only one of four patients with systemic hypertension showed more than one abnormality in pulmonary function. Thc three patients with cardiographic evidence of pulmonary hypertension had multiple abnormalities with, in particular, a marked reduction in diffusing capacity; compliance was not measured in two.
In general, the seven patients with multiple defects in pulmonary function had the most severe impairment of exercise tolerance, basal crepitations, and abnormal chest radiographs, but there were notable exceptions. One patient (No. 14) claimed no impairment of exercise tolerance and had no basal crepitations, and two patients (Nos. 5 and 14) had normal chest radiographs.
HISTOLOGY Specimens of lung were examined in two subjects. One patient (No. 2) died after the rapid development of malignant hypertension with renal failure. Macroscopically, the pleural and cut surface of the lungs appeared normal. Microscopically (Fig. 5) , cystic spaces, some of which were lined with bronchiolar epithelium, replaced the normal alveolar architecture. The interstitial tissue contained increased amounts of fibrous tissue. Patchy myocardial fibrosis with normal coronary vessels was an additional feature.
A lung biopsy (Fig. 6 ) in a second subject (No. 13) showed replacement of normal lung architecture by cysts lined with a columnar epithelium. The interstitial tissue showed a marked increase in smooth muscle, fibrous tissue, and hyaline material. Peribronchial giant cell systems with vacuolated cytoplasm were scattered throughout. Some pulmonary vessels showed proliferation of the media and intima but no evidence of fibrinoid necrosis.
DISCUSSION
The interpretation of correlations between the clinical features and the functional findings in the patients studied is of necessity limited to specific cases; generalizations based on the whole group are not only biased according to the selection of the patients in the series but also fail to reflect the variation in the clinical, radiological, electrocardiographic, and functional findings. The variability of the respiratory symptoms paralleled the functional findings. The absence of shortness of breath in half of the patients studied did not necessarily imply normal lung function, a finding common to other diffuse lung diseases. The presence of chronic bronchitis in non-smokers, beginning after the onset of symptoms of scleroderma, suggests the possibility of bronchial involvement, as indicated by the pathological studies of Getzowa (1945) and of Talbott and Ferrandis (1956) , who commented on fibrinoid changes in the bronchial mucosa. Similarly, the presence of bronchiectasis has been emphasized by Spain and Thomas (1950) , but other workers (Hayman and Hunt, 1952; Murphy, Krainin, and Gerson, 1941 ) report bronchograms as being usually normal. Descriptions of pleural lesions in necropsied patients have not been infrequent (Getzowa, 1945; Orabona and Albano, 1958) but the rarity of symptoms of pleurisy emphasized by Opie (1955) clinical or radiological evidence of residual abnormality.
The radiological appearances of pulmonary scleroderma have been classified by Garland and Sisson (1954) into (i) diffuse or localized fibrosis, (ii) diffuse or localized nodulation, (iii) subpleural 'cystic disease' (basal), and (iv) calcification. The earlier claim by Pugh (1948) that the appearances were diagnostic appears difficult to substantiate. In this study radiological abnormalities in the lungs were present in approximately a quarter of the series and the changes were not specific to scleroderma. Most of the patients with radiographic changes had severe defects in pulmonary function, suggesting that the radiograph detects only the more severe pathological changes.
Systemic hypertension was present in four patients and may have been related to scleroderma lesions in the kidney (confirmed by biopsy in one instance, No. 9). The presence of hypertensive left ventricular failure might simulate the clinical and functional aspects of scleroderma of the lung, Pulmonary function in scieroderma but this does not explain the abnormalities in the present series. Recently Oram and Stokes (1961) have indicated the frequency of myocardial involvement in scleroderma. Of interest in this study were electrocardiographic findings of non-specific T wave changes in one patient, radiological evidence of cardiac enlargement in another, and, in a third subject, patchy myocardial fibrosis at necropsy.
Pulmonary hypertension in scleroderma has been discussed by Opie (1955) , who described its occurrence with minimal radiological abnormalities in the lung fields. The pathological studies of Matsui (1924) and of Weiss, Stead, Warren, and Bailey (1943) , demonstrating the marked intimal proliferation of the pulmonary arterioles, point to vascular obstruction as probably the most significant factor in the rise of pressure. Sackner, Akgun, Kimbel, and Lewis (1962) note a high incidence of pulmonary hypertension in scleroderma and consider that this is not necessarily correlated with the clinical, radiological, or electrocardiographic signs. In the present study patients with clinical and electrocardiographic evidence of pulmonary hypertension all had gross functional defects with a low diffusing capacity, although the development of severe pulmonary hypertension with minimal radiological changes in the lung fields in one patient was notable.
Some authors (Finlay, 1889; Dinkler, 1891 Lewin and Heller, 1895) recorded the presence of respiratory symptoms and necropsy evidence of abnormal pulmonary fibrosis, but they attributed these changes to a reduction in mobility of the chest wall by the skin changes. The results of this study and those of others (Adhikari, Bianchi, Boushy, Sakamoto, and Lewis, 1962) indicate the lack of correlation between changes in the chest wall and impairment of pulmonary function. Harper (1953) A notable feature of the functional studies was the poor correlation between different tests, so that even in patients with severe defects all parameters of lung function were not necessarily affected. In patients with a single functional abnormality there was no one test consistently abnormal, although an increased ventilatory response to exercise was the most frequently found single defect. Wilson, Rodnan, and Robin (1962) , and Catterall and Rowell (1963) suggested that a fall in diffusing capacity was possibly the earliest abnormality detectable, but this is not confirmed in the present study.
Classifications of scleroderma into local and general types based on the distribution of the cutaneous manifestations have received attention (Leading Article, 1961) , and, in particular, skin changes localized to the fingers have been regarded by some authors (O'Leary and Waisman, 1943; Brunsting, 1959) as indicating a good prognosis. The present study suggests that neither the duration of the cutaneous symptoms nor the localization of the skin lesions allows prediction of the extent or severity of pulmonary involvement. It remains to be seen to what extent the accuracy of prognosis can be improved by the quantitative functional assessment of pulmonary involvement.
SUMMARY
A study of pulmonary function was made in 22 patients with scleroderma. Particular attention was paid to the relation between the clinical, radiographic, electrocardiographic, and functional findings. In general, a reduction in ventilatory capacity, lung volumes, compliance, and diffusing capacity with an increased ventilatory response to exercise was found, but individual variation in the functional defects was striking. The lack of correlation between the extent of the cutaneous lesions and the radiological changes in the lungs with functional impairment was a notable finding. 
